Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
4
×
life sciences
national blog main
alnylam pharmaceuticals
boston
clinical trials
national top stories
new york blog main
new york top stories
onpattro
patisiran
pfizer
rna interference
san diego blog main
san diego top stories
akcea therapeutics
drugs
hereditary transthyretin amyloidosis
inotersen
nobel prize
san francisco blog main
san francisco top stories
tafamidis
a2 biotherapeutics
acute hepatic porphyrias
aduro biotech
agency
akili interactive labs
akin akinc
alicia hager
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
aminolevulinic acid
andrew fire
arca biopharma
arch venture partners
What
rnai
4
×
alnylam
drug
fda
medicine
interference
pharmaceuticals
rna
afternoon
ago
alliance
alnylam’s
approval
approved
approves
bio
bristol
buy
calls
cells
changing
color
crispr
days
ema
employ
europe
follows
gene
gets
growing
harmful
history
hits
hours
indicated
kudos
landmark
leaves
make
Language
unset
Current search:
rnai
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug